Poor clinical and virological outcome of nucleos(t)ide analogue monotherapy in HBV/HDV co-infected patients
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Poor clinical and virological outcome of nucleos(t)ide analogue monotherapy in HBV/HDV co-infected patients
Authors
Keywords
-
Journal
MEDICINE
Volume 100, Issue 28, Pages e26571
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2021-07-15
DOI
10.1097/md.0000000000026571
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High rates of cirrhosis and severe clinical events in patients with HBV/HDV co-infection: longitudinal analysis of a German cohort
- (2020) Jan-Hendrik Bockmann et al. BMC GASTROENTEROLOGY
- Hepatitis delta genotype 5 is associated with favourable disease outcome and better response to treatment compared to genotype 1
- (2020) Michelle Spaan et al. JOURNAL OF HEPATOLOGY
- Chronic hepatitis D and hepatocellular carcinoma: A systematic review and meta-analysis of observational studies
- (2020) Dulce Alfaiate et al. JOURNAL OF HEPATOLOGY
- Long‐term study of hepatitis D infection at secondary care centers: the impact of viremia on liver‐related outcomes
- (2020) Habiba Kamal et al. HEPATOLOGY
- The global prevalence of hepatitis D virus infection: systematic review and meta-analysis
- (2020) Alexander J. Stockdale et al. JOURNAL OF HEPATOLOGY
- Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis Delta
- (2020) Dominique Roulot et al. JOURNAL OF HEPATOLOGY
- Ten‐year follow‐up of a randomized controlled clinical trial in chronic hepatitis delta
- (2020) Anika Wranke et al. JOURNAL OF VIRAL HEPATITIS
- New insights into HDV persistence: The role of interferon response and implications for upcoming novel therapies
- (2020) Zhenfeng Zhang et al. JOURNAL OF HEPATOLOGY
- Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial
- (2019) Heiner Wedemeyer et al. LANCET INFECTIOUS DISEASES
- Clinical outcomes in patients with hepatitis D, cirrhosis and persistent hepatitis B virus replication, and receiving long-term tenofovir or entecavir
- (2019) Giuseppina Brancaccio et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Immunomodulatory mechanism of acyclic nucleoside phosphates in treatment of hepatitis B virus infection
- (2019) Kazumoto Murata et al. HEPATOLOGY
- Long-term clinical outcomes in patients with chronic hepatitis delta: the role of persistent viraemia
- (2019) Adriana Palom et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Interferon Treatment Duration in Patients With Chronic Delta Hepatitis and its Effect on the Natural Course of the Disease
- (2018) Cihan Yurdaydin et al. JOURNAL OF INFECTIOUS DISEASES
- Genetic diversity and worldwide distribution of the deltavirus genus: A study of 2,152 clinical strains
- (2017) Frédéric Le Gal et al. HEPATOLOGY
- EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
- (2017) Pietro Lampertico et al. JOURNAL OF HEPATOLOGY
- Clinical and virological heterogeneity of hepatitis delta in different regions world-wide: The Hepatitis Delta International Network (HDIN)
- (2017) Anika Wranke et al. LIVER INTERNATIONAL
- Induction of IFN-λ3 as an additional effect of nucleotide, not nucleoside, analogues: a new potential target for HBV infection
- (2016) Kazumoto Murata et al. GUT
- Antiviral treatment and liver-related complications in hepatitis delta
- (2016) Anika Wranke et al. HEPATOLOGY
- AASLD guidelines for treatment of chronic hepatitis B
- (2015) Norah A. Terrault et al. HEPATOLOGY
- Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta-analysis
- (2015) Anna S.F. Lok et al. HEPATOLOGY
- Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013
- (2015) Aparna Schweitzer et al. LANCET
- Efficacy of prolonged tenofovir therapy on hepatitis delta in HIV-infected patients
- (2014) Vincent Soriano et al. AIDS
- Life Expectancy in Patients With Chronic HCV Infection and Cirrhosis Compared With a General Population
- (2014) Adriaan J. van der Meer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Development and evaluation of a baseline-event-anticipation score for hepatitis delta
- (2014) B. Calle Serrano et al. JOURNAL OF VIRAL HEPATITIS
- High Serum Levels of HDV RNA Are Predictors of Cirrhosis and Liver Cancer in Patients with Chronic Hepatitis Delta
- (2014) Raffaella Romeo et al. PLoS One
- Reduction of Hepatitis B Surface Antigen and Covalently Closed Circular DNA by Nucleos(t)ide Analogues of Different Potency
- (2013) Danny Ka-Ho Wong et al. Clinical Gastroenterology and Hepatology
- Prevalence and clinical course of hepatitis delta infection in Greece: A 13-year prospective study
- (2013) Emanuel K. Manesis et al. JOURNAL OF HEPATOLOGY
- Entecavir Treatment of Chronic Hepatitis D
- (2012) G. Kabacam et al. CLINICAL INFECTIOUS DISEASES
- HBeAg-positive hepatitis delta: virological patterns and clinical long-term outcome
- (2012) Benjamin Heidrich et al. LIVER INTERNATIONAL
- Treatment Options for Hepatitis Delta Virus Infection
- (2012) Benjamin Heidrich et al. Current Infectious Disease Reports
- Hepatitis delta virus
- (2011) Sarah A Hughes et al. LANCET
- Peginterferon plus Adefovir versus Either Drug Alone for Hepatitis Delta
- (2011) Heiner Wedemeyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Aktualisierung der S 3-Leitlinie zur Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion
- (2011) M. Cornberg et al. ZEITSCHRIFT FUR GASTROENTEROLOGIE
- Outcome of chronic delta hepatitis in Italy: A long-term cohort study
- (2010) Grazia Anna Niro et al. JOURNAL OF HEPATOLOGY
- Clinical outcome of acute and chronic hepatitis delta over time: a long-term follow-up study
- (2010) M. Buti et al. JOURNAL OF VIRAL HEPATITIS
- A 28-Year Study of the Course of Hepatitis Δ Infection: A Risk Factor for Cirrhosis and Hepatocellular Carcinoma
- (2009) Raffaella Romeo et al. GASTROENTEROLOGY
- Treatment of chronic delta hepatitis with lamivudine vs lamivudine + interferon vs interferon
- (2008) C. Yurdaydın et al. JOURNAL OF VIRAL HEPATITIS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started